Heartwood Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
MSV
VWM
SIS
QPBE
FFA
RT
WF
AAA
ACM
Heartwood Wealth Advisors's PFE Position: Q3 2026 in Review
Heartwood Wealth Advisors increased its Pfizer (PFE) stake by 4.5% in Q3 2026, buying an estimated $85.2K and bringing the position to 75,030 shares worth $2.14M. The position accounts for 0.17% of the portfolio, ranked #66.
Heartwood Wealth Advisors first reported a position in PFE in Q4 2019 and has held it in 23 quarters since. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Heartwood Wealth Advisors held 75,030 shares of Pfizer worth $2.14M as of Q3 2026.
- Heartwood Wealth Advisors bought 3,202 Pfizer shares in Q3 2026, an estimated $85.2K.
- Pfizer made up 0.17% of Heartwood Wealth Advisors's portfolio in Q3 2026, its #66 holding.
- Heartwood Wealth Advisors first reported a position in Pfizer in Q4 2019 and has held it in 23 quarters since.
- 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Heartwood Wealth Advisors's 13F filing for Q3 2026, filed 5 Oct 2026.